Home > Financial Ratios > IPCA LABORATORIES

IPCA LABORATORIES
Core EBITDA Growth

    Back to All Ratios
IPCA LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for IPCA LABORATORIES
Please provide your vote to see the results

IPCA LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 25.7837.28-23.51-14.3564.84

What is the latest Core EBITDA Growth ratio of IPCA LABORATORIES ?

The latest Core EBITDA Growth ratio of IPCA LABORATORIES is 25.78 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202525.78
Mar202437.28
Mar2023-23.51
Mar2022-14.35
Mar202164.84

How is Core EBITDA Growth of IPCA LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 25.78
-30.85
Mar2024 37.28
Positive
Mar2023 -23.51
Negative
Mar2022 -14.35
Negative
Mar2021 64.84 -

Other Financial Ratios of IPCA LABORATORIES


Compare Core EBITDA Growth ratio of peers of IPCA LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
IPCA LABORATORIES ₹43,038.9 Cr 4.7% 13.5% 27.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,704.0 Cr -0.5% 3.9% 12.1% Stock Analytics
DIVIS LABORATORIES ₹173,684.0 Cr -3.1% -0.1% 0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,093.0 Cr 3.1% 6.7% 45.5% Stock Analytics
CIPLA ₹117,699.0 Cr 1.4% 4.8% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹111,792.0 Cr 0.8% 3.9% 1.5% Stock Analytics


IPCA LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
IPCA LABORATORIES

4.7%

13.5%

27.6%

SENSEX

1%

2.9%

-6.1%


You may also like the below Video Courses